| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,999 |
6,407 |
$286K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,401 |
4,523 |
$262K |
| 80305 |
|
1,915 |
1,567 |
$21K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,931 |
1,819 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
436 |
397 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
105 |
97 |
$7K |
| 99307 |
|
447 |
427 |
$3K |
| 99406 |
|
345 |
289 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
107 |
101 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
30 |
26 |
$1K |
| 96160 |
|
103 |
98 |
$296.38 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
16 |
15 |
$152.38 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
54 |
52 |
$55.16 |
| 1160F |
|
1,142 |
982 |
$0.00 |
| 3078F |
|
721 |
646 |
$0.00 |
| 1159F |
|
1,151 |
987 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
143 |
111 |
$0.00 |
| 4004F |
|
215 |
174 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
111 |
102 |
$0.00 |
| 3079F |
|
220 |
199 |
$0.00 |
| 3075F |
|
113 |
102 |
$0.00 |
| 1036F |
|
469 |
408 |
$0.00 |
| 1034F |
|
242 |
192 |
$0.00 |
| 3074F |
|
807 |
710 |
$0.00 |
| 3008F |
|
912 |
774 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
66 |
60 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
67 |
61 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
153 |
140 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
29 |
27 |
$0.00 |